SPDR® S&P Pharmaceuticals ETF (XPH)

Delayed Data
As of Nov 14
 -0.05 / -0.13%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

No recent news for SPDR® S&P Pharmaceuticals ETF.


1 month+7.99% 3 years-2.47%
3 months+7.11% 5 years-4.10%
1 year-9.92% Since inception+8.91%
Data through 11/15/2019

Quote Details

Previous close$38.25
Open day’s range37.92 – 38.20
Net asset value (NAV)38.18 (11/14/2019)
Daily volume21,493
Average volume (3 months)76,508
Data as of 8:00pm ET, 11/14/2019

Peer Comparisonvs. Health ETFs

Performance 5-yr return-4.10%+7.05%
Expense Gross exp ratio0.35%1.24%
Risk 5 year sharpe ratio-0.120.44
Net assets$183.8M$3.1B
Average market cap$9.5B$40.0B
Average P/E20.926.1
Dividend / Share--0.26%


VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF
IXJ iShares Global Healthcare ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
RETA Reata Pharmaceuticals Inc5.74%
BMY Bristol-Myers Squibb5.03%
HZNP Horizon Therapeutics PLC4.76%
AGN Allergan4.60%
ZTS Zoetis Inc4.58%
MRK Merck4.55%
PFE Pfizer4.51%
LLY Eli Lilly and Co4.46%
JNJ Johnson & Johnson4.38%
JAZZ Jazz Pharmaceuticals PLC4.14%